Pancreatic cancer is one of the deadliest cancers worldwide, with a five-year survival rate of 13%. This poor prognosis stems ...

Researchers have discovered race-associated molecular differences in tumors that may impact the way patients with pancreatic ...

Researchers have discovered race-associated molecular differences in tumors that may impact the way patients with pancreatic ...

A novel, rapid blood test demonstrated potential for detecting early-stage pancreatic cancer, according to results of a ...

A new study from Memorial Sloan Kettering Cancer Center has shown that an RNA-based neoantigen vaccine can generate ...

Fatty pancreas disease, characterized by intra-pancreatic fat deposition, is more prevalent than diabetes, pancreatitis, and ...

A clinical trial from Memorial Sloan Kettering Cancer Center looked at the effects of a targeted mRNA vaccine on early-stage ...

Understanding your tumor biology is key to finding the right treatment for pancreatic cancer. Identifying mutations, or changes in a [...] READ MORE ...

Pifani has lost several family members to pancreatic cancer — including a cousin and uncle who both died in six months or less — so he feels “extremely fortunate.” The family has a genetic mutation ...

Pancreatic cancer is one of the deadliest cancers worldwide, with a five-year survival rate of 13%. This poor prognosis stems from both late detection ...

This month’s Research Spotlight highlights significant advancements in pancreatic cancer research and patient support.

In the seriously great news department, pancreatic cancer is expected to pass colorectal cancer as the second biggest cause ...